Product update of HNPCC MASTR Plus
We are pleased to announce the release of the new updated HNPCC MASTR™ Plus molecular assay, research use only, for identification of all mutations in the coding region of MLH1, MSH2, MSH6, PMS2 and 3’ UTR of EPCAM genes associated with the Lynch Syndrome.
Multiplicom expands its NGS product range with a MASTR kit that identifies actionable mutations in solid tumours
Niel - Belgium, March 31st, 2015 – Multiplicom N.V. announces the release of the SOMATIC 2 MASTR™ Plus kit for the detection of actionable somatic mutations in the genes EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN enabling affordable, personalized cancer treatment.
99. Jahrestagung der Deutschen Gesellschaft für Pathologie
Germany I Frankfurt
European Society of Human Genetics 2015
Scotland I Glasgow
38th European Cystic Fibrosis Conference
Belgium I Brussels
Bio International Convention
US I Philadelphia